scispace - formally typeset
J

Jose Tamez-Pena

Researcher at Monterrey Institute of Technology and Higher Education

Publications -  120
Citations -  2240

Jose Tamez-Pena is an academic researcher from Monterrey Institute of Technology and Higher Education. The author has contributed to research in topics: Osteoarthritis & Image segmentation. The author has an hindex of 22, co-authored 113 publications receiving 2016 citations. Previous affiliations of Jose Tamez-Pena include University of Rochester & University of Rochester Medical Center.

Papers
More filters
Journal ArticleDOI

SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis

TL;DR: This work developed SurvExpress, a cancer-wide gene expression database with clinical outcomes and a web-based tool that provides survival analysis and risk assessment of cancer datasets and shows the utility and simplicity of SurvExpress in two biomarker applications for breast and lung cancer.
Journal ArticleDOI

The acutely ACL injured knee assessed by MRI: are large volume traumatic bone marrow lesions a sign of severe compression injury?

TL;DR: A majority of the ACL injured knees had a cortical depression fracture, which indicates strong compressive forces to the articular surface and cartilage at the time of injury, which may constitute an additional risk factor for later knee osteoarthritis development.
Journal ArticleDOI

Unsupervised Segmentation and Quantification of Anatomical Knee Features: Data From the Osteoarthritis Initiative

TL;DR: The fully automated segmentation methodology produces reproducible cartilage volume, thickness, and shape measurements valuable for the study of OA progression.
Journal ArticleDOI

Volumetric computerized tomography as a measurement of periprosthetic acetabular osteolysis and its correlation with wear.

TL;DR: Both the feasibility of CT imaging of periacetabular osteolysis and the correlation between polyethylene wear and osteolytic volume are demonstrated, providing a potential outcome measure for clinical trials that are designed to examine interventions in this complex disease process.